Final 5-year study results of DASISION: the dasatinib versus imatinib study in treatment-naïve chronic myeloid leukemia patients trial

JE Cortes, G Saglio, HM Kantarjian… - Journal of Clinical …, 2016 - ascopubs.org
Purpose We report the 5-year analysis from the phase III Dasatinib Versus Imatinib Study in
Treatment-Naïve Chronic Myeloid Leukemia Patients (DASISION) trial, evaluating long-term …
被引用次数：1011 相关文章

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial

JE Cortes, G Saglio, HM Kantarjian… - Journal of Clinical …, 2016 - is.muni.cz
Purpose We report the 5-year analysis from the phase III Dasatinib Versus Imatinib Study in
Treatment-Naive Chronic Myeloid Leukemia Patients (DASISION) trial, evaluating long-term …

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

JE Cortes, G Saglio, HM Kantarjian… - Journal of Clinical …, 2016 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> We report the 5-year analysis from the
phase III Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia …
[HTML] nih.gov

[HTML][HTML] Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

JE Cortes, G Saglio, HM Kantarjian… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
Purpose We report the 5-year analysis from the phase III Dasatinib Versus Imatinib Study in
Treatment-Naïve Chronic Myeloid Leukemia Patients (DASISION) trial, evaluating long-term …

Final 5-year study results of DASISION: The dasatinib versus imatinib study in treatment-Naïve chronic myeloid leukemia patients trial

JE Cortes, G Saglio… - Journal of …, 2016 - mdanderson.elsevierpure.com
Purpose: We report the 5-year analysis from the phase III Dasatinib Versus Imatinib Study in
Treatment-Naïve Chronic Myeloid Leukemia Patients (DASISION) trial, evaluating long-term …

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

JE Cortes, G Saglio, HM Kantarjian… - Journal of clinical …, 2016 - pubmed.ncbi.nlm.nih.gov
Purpose We report the 5-year analysis from the phase III Dasatinib Versus Imatinib Study in
Treatment-Naïve Chronic Myeloid Leukemia Patients (DASISION) trial, evaluating long-term …
[PDF] semanticscholar.org

[PDF][PDF] Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

NP Shah, C Chuah, L Casanova… - J Clin …, 2016 - pdfs.semanticscholar.org
Purpose We report the 5-year analysis from the phase III Dasatinib Versus Imatinib Study in
Treatment-Naıve Chronic Myeloid Leukemia Patients (DASISION) trial, evaluating long-term …

Final 5-year study results of DASISION: The dasatinib versus imatinib study in treatment-Naïve chronic myeloid leukemia patients trial

JE Cortes, G Saglio, HM Kantarjian… - JOURNAL OF …, 2016 - iris.unito.it
PURPOSE: We report the 5-year analysis from the phase III Dasatinib Versus Imatinib Study
in Treatment-Naïve Chronic Myeloid Leukemia Patients (DASISION) trial, evaluating long …

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial

JE Cortes, G Saglio, HM Kantarjian, M Baccarani… - 2016 - med.muni.cz
Purpose We report the 5-year analysis from the phase III Dasatinib Versus Imatinib Study in
Treatment-Naive Chronic Myeloid Leukemia Patients (DASISION) trial, evaluating long-term …

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial.

JE Cortes, G Saglio, HM Kantarjian… - Journal of Clinical …, 2016 - europepmc.org
Purpose We report the 5-year analysis from the phase III Dasatinib Versus Imatinib Study in
Treatment-Naïve Chronic Myeloid Leukemia Patients (DASISION) trial, evaluating long-term …